DRMA
DRMA
NASDAQ · Biotechnology

Dermata Therapeutics Inc

$0.72
+0.00 (+0.07%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +5,323.8% upside
Low Target $26.82
Average Target $38.78
High Target $44.92
Current Price $0.72
Current
$0.72
Target
$38.78
$26.82 $38.78 avg $44.92
Scenario Analysis
Bear Case
$26.82
3,651.0%
Low target
Base Case
$38.78
+5,323.8%
Avg target
Bull Case
$44.92
+6,182.5%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$4.66
-84.7% from high
52-Week Low
$0.60
+18.5% from low
Target vs 52W High
$38.78
+732.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%